Treatment of Bio-Naïve Patients or Those Progressing on Topical or Biologic Atopic Dermatitis Therapy

Key Takeaways

• Bio-naïve patients with moderate atopic dermatitis often start with topical corticosteroids or calcineurin inhibitors as first-line treatments.
• Disease progression on topical treatments may necessitate systemic therapies or phototherapy to achieve better disease control.
• Patients not responding to biologic therapy might benefit from switching biologics or adding adjunctive treatments to their regimen.
• Individualized treatment plans are crucial, taking into account patient-specific factors and potential side effects to optimize outcomes.